Harrow (HROW) Interest & Investment Income (2010 - 2014)
Harrow (HROW) recorded quarterly Interest & Investment Income of $5955.0 in Q4 2014, down 20.62% quarter-over-quarter from $7502.0 in Q3 2014, and down 47.33% on a YoY basis from $11307.0 in Q4 2013.
Harrow (HROW) Interest & Investment Income (2010 - 2014) Analysis & Trends
Harrow's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $5955.0 for Q4 2014.
- In Q4 2014, Interest & Investment Income fell 47.33% year-over-year to $5955.0; the TTM figure through Dec 2014 stood at $32446.0 (down 25.85% YoY), while the FY2014 annual figure was $32446.0, down 25.85% from the prior year.
- Interest & Investment Income was $5955.0 for Q4 2014 at Harrow, down from $7502.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $12940.0 in Q2 2013 to a low of $29.0 in Q4 2010.
- Historically, Interest & Investment Income has averaged $6570.7 across 4 years, with a median of $6511.5 in 2013.
- The sharpest annual moves came in 2013 and 2014: Interest & Investment Income jumped 194.72% in 2013, then sank 47.33% in 2014.
- A 4-year view of Interest & Investment Income shows it stood at $29.0 in 2010, then soared by 19227.59% to $5605.0 in 2012, then soared by 101.73% to $11307.0 in 2013, then tumbled by 47.33% to $5955.0 in 2014.
- The last three Interest & Investment Income figures came in at $5955.0 (Q4 2014), $7502.0 (Q3 2014), and $8680.0 (Q2 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Harrow | 1.34 Bn | 1.24 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 5,955.00 |
| Sep 30, 2014 | 7,502.00 |
| Jun 30, 2014 | 8,680.00 |
| Mar 31, 2014 | 10,309.00 |
| Dec 31, 2013 | 11,307.00 |
| Sep 30, 2013 | 12,440.00 |
| Jun 30, 2013 | 12,940.00 |
| Mar 31, 2013 | 7,068.00 |
| Dec 31, 2012 | 5,605.00 |
| Sep 30, 2012 | 4,221.00 |
| Jun 30, 2012 | 5,584.00 |
| Dec 31, 2010 | 29.00 |
| Sep 30, 2010 | 215.00 |
| Jun 30, 2010 | 135.00 |